Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population

Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study...

Full description

Saved in:
Bibliographic Details
Published inBMC gastroenterology Vol. 21; no. 1; pp. 88 - 7
Main Authors Zhang, Qing, Zhu, Yueli, Yu, Wanjiang, Xu, Zhipeng, Zhao, Zhenzhen, Liu, Shousheng, Xin, Yongning, Lv, Kuirong
Format Journal Article
LanguageEnglish
Published London BioMed Central 25.02.2021
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1471-230X
1471-230X
DOI10.1186/s12876-021-01675-y

Cover

Abstract Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. Patients and methods MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. Results A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. Conclusions The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.
AbstractList Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. Patients and methods MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. Results A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. Conclusions The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.
Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.
Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. Patients and methods MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. Results A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. Conclusions The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.
Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population.BACKGROUNDSeveral molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population.MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0.PATIENTS AND METHODSMRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0.A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions.RESULTSA total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions.The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.CONCLUSIONSThe molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.
Abstract Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. Patients and methods MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. Results A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. Conclusions The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.
Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. Patients and methods MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. Results A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. Conclusions The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD. Keywords: Non-alcoholic fatty liver disease, MRI-PDFF, Molecular prediction model
Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these molecular prediction models remains need to be verified based on the most accurate NAFLD diagnostic method. The aim of this study was to verify the accuracy of three molecular prediction models Fatty liver index (FLI), NAFLD liver fat score system (NAFLD LFS), and Liver fat (%) in the prediction and diagnosis of NAFLD in MRI-PDFF diagnosed Chinese Han population. MRI-PDFF was used to diagnose the hepatic steatosis of all the subjects. Information such as name, age, lifestyle, and major medical histories were collected and the clinical parameters were measured by the standard clinical laboratory techniques. The cut-off values of each model for the risk of NAFLD were calculated based on the MRI-PDFF results. All data were analyzed using the statistical analysis software SPSS 23.0. A total of 169 subjects were recruited with the matched sex and age. The ROC curves of FLI, NAFLD LFS, and Liver fat (%) models were plotted based on the results of MRI-PDFF. We founded that the accuracy of FLI, NAFLD LFS, and Liver fat (%) models for the prediction and diagnosis of NAFLD were comparative available in Chinese Han population as well as the validity of them in other ethnics and regions. The molecular prediction models FLI, NAFLD LFS, and Liver fat (%) were comparative available for the prediction and diagnosis of NAFLD in Chinese Han population. MRI-PDFF could be used as the golden standard to develop the new molecular prediction models for the prediction and diagnosis of NAFLD.
ArticleNumber 88
Audience Academic
Author Zhao, Zhenzhen
Yu, Wanjiang
Xu, Zhipeng
Lv, Kuirong
Zhu, Yueli
Zhang, Qing
Xin, Yongning
Liu, Shousheng
Author_xml – sequence: 1
  givenname: Qing
  surname: Zhang
  fullname: Zhang, Qing
  organization: Department of Radiology, Qingdao Municipal Hospital
– sequence: 2
  givenname: Yueli
  surname: Zhu
  fullname: Zhu, Yueli
  organization: Department of Radiology, Qingdao Municipal Hospital
– sequence: 3
  givenname: Wanjiang
  surname: Yu
  fullname: Yu, Wanjiang
  organization: Department of Radiology, Qingdao Municipal Hospital
– sequence: 4
  givenname: Zhipeng
  surname: Xu
  fullname: Xu, Zhipeng
  organization: Department of Radiology, Qingdao Municipal Hospital
– sequence: 5
  givenname: Zhenzhen
  surname: Zhao
  fullname: Zhao, Zhenzhen
  organization: Clinical Research Center, Qingdao Municipal Hospital
– sequence: 6
  givenname: Shousheng
  surname: Liu
  fullname: Liu, Shousheng
  organization: Clinical Research Center, Qingdao Municipal Hospital
– sequence: 7
  givenname: Yongning
  surname: Xin
  fullname: Xin, Yongning
  email: xinyongning@163.com
  organization: Department of Infectious Disease, Qingdao Municipal Hospital
– sequence: 8
  givenname: Kuirong
  surname: Lv
  fullname: Lv, Kuirong
  email: lvkr5169@163.com
  organization: Department of Radiology, Qingdao Municipal Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33632126$$D View this record in MEDLINE/PubMed
BookMark eNp9ksuO0zAUhiM0iLnAC7BAltiwyeBbHGeDNGopU6lchEBiZzm207okdrETpD4A743TDDPTERplkej4_7_jc_KfZyfOO5NlLxG8RIiztxFhXrIcYpRDxMoi3z_JzhAtUY4J_HFy7_s0O49xCyEqOSbPslNCGMEIs7Psz9zKtfOxtwpIpYYg1R7IGE2MnXE98A3ofGvU0MoAdsFoq3rrXSpq04LGB9BvDAg2_hyln64WqzmoZTQaJNHHr8v8y3yxAHpqkqqzjXUmGnAtHdj5XcKOuOfZ00a20by4eV9k3xfvv82u89XnD8vZ1SpXDJZ9XjdcU1lKBEnDFEeQq4pySBWGFSmaknCNCCsNRDQdNqimBFW4ILwhqCykIhfZcuJqL7diF2wnw154acWh4MNayJBW0RqBaqULzqta6prWvJIE00LxtNFCIwpH1ruJtRvqzmiVthVkewQ9PnF2I9b-tygryBklCfDmBhD8r8HEXnQ2KtO20hk_RIFpRUn6saxM0tcPpFs_BJdWJXABcSIWiN2p1jINYF3jU181QsUVKwhjpIIj6_I_qvRo01mVEtbYVD8yvLo_6O2E_0KUBHgSqOBjDKa5lSAoxqSKKakiJVUckir2ycQfmJTtD2FI17Ht41YyWWPq49Ym3G3jEddf7jn7hg
CitedBy_id crossref_primary_10_3389_fcvm_2022_938902
crossref_primary_10_5527_wjn_v13_i3_97214
crossref_primary_10_1159_000530531
crossref_primary_10_3390_diagnostics13213316
crossref_primary_10_1186_s12944_023_01966_1
crossref_primary_10_1007_s13105_023_00991_z
crossref_primary_10_1186_s12876_021_02088_7
crossref_primary_10_1111_apt_17914
Cites_doi 10.1053/j.gastro.2015.11.048
10.1002/hep.23345
10.3748/wjg.v19.i40.6735
10.1007/s00134-019-05594-1
10.1016/j.cgh.2018.05.058
10.1016/j.diabet.2016.11.006
10.1016/j.phrs.2018.07.014
10.1111/liv.13653
10.1111/jgh.12557
10.1148/radiol.14140754
10.1111/liv.13413
10.1136/bmj.2.5402.177
10.1002/hep.29797
10.1002/jmri.24452
10.1002/hep.30251
10.3390/nu11030705
10.1038/s41591-018-0104-9
10.1002/hep.30350
10.1002/hep.21346
10.1007/s00330-019-06072-4
10.1053/j.gastro.2017.06.005
10.15252/msb.20188793
10.1186/1471-230X-6-33
10.1002/mrm.26228
10.1002/hep.26455
10.1038/nrgastro.2017.109
10.1053/j.gastro.2009.06.005
10.1016/j.jhep.2017.11.013
10.1136/gutjnl-2012-302789
10.1002/hep.29596
10.1148/radiol.10100659
10.1001/jama.2015.5370
10.1002/dmrr.3158
10.1002/jmri.24321
10.1001/jamapediatrics.2014.2702
ContentType Journal Article
Copyright The Author(s) 2021
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7QR
7T5
7X7
7XB
88E
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12876-021-01675-y
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central
Engineering Research Database
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Biotechnology and BioEngineering Abstracts
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-230X
EndPage 7
ExternalDocumentID oai_doaj_org_article_1bcd5889badb4b89a3245c84715d140c
PMC7908643
A653663907
33632126
10_1186_s12876_021_01675_y
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 31770837
  funderid: http://dx.doi.org/10.13039/501100001809
– fundername: National Natural Science Foundation of China
  grantid: 31770837
– fundername: ;
  grantid: 31770837
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QP
7QR
7T5
7XB
8FD
8FK
AZQEC
DWQXO
FR3
H94
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c607t-bf8d4a7a103f6c8108c94804c20935f738d1367e014810f1b43192538f3175ac3
IEDL.DBID M48
ISSN 1471-230X
IngestDate Wed Aug 27 01:31:09 EDT 2025
Thu Aug 21 17:29:17 EDT 2025
Thu Sep 04 19:44:11 EDT 2025
Fri Jul 25 21:12:16 EDT 2025
Tue Jun 17 21:27:20 EDT 2025
Tue Jun 10 20:49:25 EDT 2025
Thu Apr 03 06:53:04 EDT 2025
Tue Jul 01 04:12:05 EDT 2025
Thu Apr 24 23:12:40 EDT 2025
Sat Sep 06 07:35:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Non-alcoholic fatty liver disease
Molecular prediction model
MRI-PDFF
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-bf8d4a7a103f6c8108c94804c20935f738d1367e014810f1b43192538f3175ac3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.1186/s12876-021-01675-y
PMID 33632126
PQID 2502790516
PQPubID 44673
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_1bcd5889badb4b89a3245c84715d140c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7908643
proquest_miscellaneous_2494301667
proquest_journals_2502790516
gale_infotracmisc_A653663907
gale_infotracacademiconefile_A653663907
pubmed_primary_33632126
crossref_primary_10_1186_s12876_021_01675_y
crossref_citationtrail_10_1186_s12876_021_01675_y
springer_journals_10_1186_s12876_021_01675_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-25
PublicationDateYYYYMMDD 2021-02-25
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-25
  day: 25
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC gastroenterology
PublicationTitleAbbrev BMC Gastroenterol
PublicationTitleAlternate BMC Gastroenterol
PublicationYear 2021
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References M Schetz (1675_CR33) 2019; 45
P Bedossa (1675_CR7) 2018; 38
Z Younossi (1675_CR2) 2018; 15
V Nobili (1675_CR27) 2015; 169
G Bedogni (1675_CR17) 2006; 6
S Saokaew (1675_CR32) 2017; 37
Z Younossi (1675_CR1) 2019; 69
S Fiorucci (1675_CR3) 2018; 134
M Noureddin (1675_CR12) 2013; 58
S Bonekamp (1675_CR8) 2014; 39
G Tarantino (1675_CR28) 2013; 19
1675_CR14
A Kotronen (1675_CR18) 2009; 137
I Croci (1675_CR34) 2013; 62
1675_CR13
1675_CR35
A Tang (1675_CR25) 2015; 274
MS Middleton (1675_CR29) 2017; 153
E Vilar-Gomez (1675_CR31) 2018; 68
Y Ma (1675_CR22) 2019; 69
WK Chan (1675_CR10) 2014; 29
MS Middleton (1675_CR15) 2018; 67
L Niu (1675_CR19) 2019; 15
ME Rinella (1675_CR5) 2015; 313
RB Merriman (1675_CR6) 2006; 44
J Gu (1675_CR16) 2019; 29
1675_CR21
C Caussy (1675_CR11) 2018; 68
1675_CR20
K Kantartzis (1675_CR30) 2017; 43
1675_CR9
1675_CR26
1675_CR23
1675_CR24
SL Friedman (1675_CR4) 2018; 24
References_xml – ident: 1675_CR14
  doi: 10.1053/j.gastro.2015.11.048
– ident: 1675_CR9
  doi: 10.1002/hep.23345
– volume: 19
  start-page: 6735
  issue: 40
  year: 2013
  ident: 1675_CR28
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v19.i40.6735
– volume: 45
  start-page: 757
  issue: 6
  year: 2019
  ident: 1675_CR33
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-019-05594-1
– ident: 1675_CR21
  doi: 10.1016/j.cgh.2018.05.058
– volume: 43
  start-page: 229
  issue: 3
  year: 2017
  ident: 1675_CR30
  publication-title: Diabetes Metab
  doi: 10.1016/j.diabet.2016.11.006
– volume: 134
  start-page: 289
  year: 2018
  ident: 1675_CR3
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2018.07.014
– volume: 38
  start-page: 64
  issue: Suppl 1
  year: 2018
  ident: 1675_CR7
  publication-title: Liver Int
  doi: 10.1111/liv.13653
– volume: 29
  start-page: 1470
  issue: 7
  year: 2014
  ident: 1675_CR10
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/jgh.12557
– volume: 274
  start-page: 416
  issue: 2
  year: 2015
  ident: 1675_CR25
  publication-title: Radiology
  doi: 10.1148/radiol.14140754
– volume: 37
  start-page: 1535
  issue: 10
  year: 2017
  ident: 1675_CR32
  publication-title: Liver Int
  doi: 10.1111/liv.13413
– ident: 1675_CR23
  doi: 10.1136/bmj.2.5402.177
– volume: 68
  start-page: 763
  issue: 2
  year: 2018
  ident: 1675_CR11
  publication-title: Hepatology
  doi: 10.1002/hep.29797
– ident: 1675_CR24
  doi: 10.1002/jmri.24452
– volume: 69
  start-page: 2672
  issue: 6
  year: 2019
  ident: 1675_CR1
  publication-title: Hepatology
  doi: 10.1002/hep.30251
– ident: 1675_CR20
  doi: 10.3390/nu11030705
– volume: 24
  start-page: 908
  issue: 7
  year: 2018
  ident: 1675_CR4
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0104-9
– volume: 69
  start-page: 1504
  issue: 4
  year: 2019
  ident: 1675_CR22
  publication-title: Hepatology
  doi: 10.1002/hep.30350
– volume: 44
  start-page: 874
  issue: 4
  year: 2006
  ident: 1675_CR6
  publication-title: Hepatology
  doi: 10.1002/hep.21346
– volume: 29
  start-page: 3564
  issue: 7
  year: 2019
  ident: 1675_CR16
  publication-title: Eur Radiol
  doi: 10.1007/s00330-019-06072-4
– volume: 153
  start-page: 753
  issue: 3
  year: 2017
  ident: 1675_CR29
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2017.06.005
– volume: 15
  start-page: e8793
  issue: 3
  year: 2019
  ident: 1675_CR19
  publication-title: Molecular systems biology
  doi: 10.15252/msb.20188793
– volume: 6
  start-page: 33
  year: 2006
  ident: 1675_CR17
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230X-6-33
– ident: 1675_CR35
  doi: 10.1002/mrm.26228
– volume: 58
  start-page: 1930
  issue: 6
  year: 2013
  ident: 1675_CR12
  publication-title: Hepatology
  doi: 10.1002/hep.26455
– volume: 15
  start-page: 11
  issue: 1
  year: 2018
  ident: 1675_CR2
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2017.109
– volume: 137
  start-page: 865
  issue: 3
  year: 2009
  ident: 1675_CR18
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2009.06.005
– volume: 68
  start-page: 305
  issue: 2
  year: 2018
  ident: 1675_CR31
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.11.013
– volume: 62
  start-page: 1625
  issue: 11
  year: 2013
  ident: 1675_CR34
  publication-title: Gut
  doi: 10.1136/gutjnl-2012-302789
– volume: 67
  start-page: 858
  issue: 3
  year: 2018
  ident: 1675_CR15
  publication-title: Hepatology
  doi: 10.1002/hep.29596
– ident: 1675_CR13
  doi: 10.1148/radiol.10100659
– volume: 313
  start-page: 2263
  issue: 22
  year: 2015
  ident: 1675_CR5
  publication-title: JAMA
  doi: 10.1001/jama.2015.5370
– ident: 1675_CR26
  doi: 10.1002/dmrr.3158
– volume: 39
  start-page: 1525
  issue: 6
  year: 2014
  ident: 1675_CR8
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.24321
– volume: 169
  start-page: 170
  issue: 2
  year: 2015
  ident: 1675_CR27
  publication-title: JAMA Pediatr
  doi: 10.1001/jamapediatrics.2014.2702
SSID ssj0017823
Score 2.3125217
Snippet Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the...
Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the accuracy of these...
Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but the...
Abstract Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis the risk of NAFLD, but...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 88
SubjectTerms Accuracy
Age
Biopsy
Blood pressure
Body mass index
China
Diabetes
Diagnosis
Evaluation
Fatty liver
Gastroenterology
Hepatitis
Hepatobiliary and pancreatic disorders
Hepatology
Humans
Internal Medicine
Liver - diagnostic imaging
Liver diseases
Magnetic Resonance Imaging
Medicine
Medicine & Public Health
Metabolic syndrome
Molecular diagnostic techniques
Molecular modelling
Molecular prediction model
MRI-PDFF
Non-alcoholic fatty liver disease
Non-alcoholic Fatty Liver Disease - diagnostic imaging
Prediction models
Research Article
ROC Curve
Software
Statistical analysis
Steatosis
Ultrasonic imaging
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eivm1dJYLgQcP2I52kj6NjM4qziLiwt5BXo6A9wzwO8wP2f29V-uH2inrx2qlMJ6lK5atJ9VeEvBQQcSnpORNgHIyLwFllhGO5Mg7p2IOMN6bLU7E44x_Py_Mrpb4wJ6yjB-4W7iSzzpdKVdZ4y62qDCCA0qFPLT0EBw69b1qlQzDV3x_AuVcMn8gocbIFLywx2RZDZ4DI7DA5hiJb_-8--cqhdD1h8tqtaTyM6jvkdo8i6awb_V1yI7T3yM1lf09-n1zMuww6aKbGuf3GuAM1IwknXTX051AXl6432A8VRGNdHAo4lgIupJh2jqKns_rTnOJ55ykILb98YJ_ndU199xJ4ilW4wzbQhWnpeiwJ9oCc1e-_vluwvuACcyKVO2Yb5bmRJkuLRjiVpcpVXKXc5Xhd2shCeWR4C_gvZJY2mQX0UeXgMhtEIaDch-SoXbXhMaHey9w2pvKpk9yo0nDJrSts6cGhBdskJBvWX7uejRyLYvzQMSpRQnc606AzHXWmDwl5PfZZd1wcf5V-i2odJZFHOz4A69K9del_WVdCXqFRaNztMDxn-o8WYJLIm6VnoiwAs1WpTMjxRBJ2qZs2D2aley-x1QA_80iQJhLyYmzGnpj51obVHmQ4EuRnQsBPPOqscJxSUYgCoAf0lhP7nMx52tJ-_xY5xOG1CsBoQt4MlvxrWH9e0yf_Y02fklt53Ik5y8tjcrTb7MMzQHY7-zxu4ksddkeE
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JjtQwELVgkBAXxE5gQEZC4gDWZHFs54QamqhB9AghRuqb5SUBJEiaXg79Afw3Vc4yZBBzjctJnCpXPduVV4Q8F7DiUtJzJsA4GBcVZ4URjqXKOKRjr2Q4MV2eisUZ_7DKV_2G27ZPqxx8YnDUvnW4R34CoToNZFLi9foXw6pReLral9C4Sq4F6jKwZ7kaF1wJRL9s-FFGiZMt-GKJKbe4gAagzA6TYBQ4-__1zH-FpotpkxfOTkNIKm-Rmz2WpLNO-bfJlaq5Q64v-9Pyu-T3vMujg2ZqnNtvjDtQM1Jx0ramP4fquHS9wX6oJhqq41BAsxTQIcXkcxQ9nZUf5xSjnqcgtPz8nn2alyX13UPgKtbirrYVXZiGrsfCYPfIWfnuy9sF68suMCdiuWO2Vp4baZI4q4VTSaxcwVXMXYqHprXMlEeetwr3IpO4TixgkCIFx1kjFgEV3ydHTdtUDwn1Xqa2NoWPneRG5YZLbl1mcw9urbJ1RJLh-2vXc5JjaYwfOqxNlNCdzjToTAed6UNEXo591h0jx6XSb1CtoySyaYcL7ear7ienTqzzuVKFNd5yqwoDKDN3GLdzDwtQF5EXaBQa5zy8njP9rwswSGTP0jORZ4DcilhG5HgiCXPVTZsHs9K9r9jqc8uOyLOxGXti_ltTtXuQ4UiTnwgBt3jQWeE4pCwTGQAQ6C0n9jkZ87Sl-f4tMInDYxVA0oi8Giz5_LX-_00fXT6Kx-RGGuZYytL8mBztNvvqCSC3nX0apucf-NE-6A
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bq9QwEA56BPFFvFs9SgTBBw32kibp43rWsop7EPHAeQu5FQXtLnt52B_g_3YmvXh6vICvzUzbdCaZL53kG0KeC1hxKek5E-AcjIvAWWWEY7kyDunYg4wZ0-WpWJzx9-fleU-Tg2dhLubvMyVeb2H-lLhNFhe9AG7Z4Sq5VmaFiIlZcTJmDCDSFcOhmD_qTQJP5Of_fRa-EIYub5G8lCeN4ae-RW72uJHOOkPfJldCe4dcX_aZ8bvkx7zbMwfN1Di33xh3oGak3aSrhn4fKuHS9Qb10CQ0VsKhgFwpIEGKG81R9HRWf5hTjHCegtDy0zv2cV7X1HcPgatYdztsA12Ylq7HImD3yFn99vPJgvUlFpgTqdwx2yjPjTRZWjTCqSxVruIq5S7HBGkjC-WR0y3gf8csbTILeKPKYZJsEHeAOe-To3bVhoeEei9z25jKp05yo0rDJbeusKWHKSzYJiHZ8P216_nHsQzGNx3XIUrozmYabKajzfQhIS9HnXXHvvFP6Tdo1lESmbPjBXAo3Q9EnVnnS6Uqa7zlVlUGEGXpMEaXHhabLiEv0Ck0jm94PWf6YwrQSWTK0jNRFoDSqlQm5HgiCePSTZsHt9L9vLDVADjzSIkmEvJsbEZN3OvWhtUeZDhS4mdCwC0edF44dqkAxwewAdpy4p-TPk9b2q9fIms4PFYB_EzIq8GTf73W37_po_8Tf0xu5HHM5Swvj8nRbrMPTwC17ezTOFx_AmUCOGA
  priority: 102
  providerName: Springer Nature
Title Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population
URI https://link.springer.com/article/10.1186/s12876-021-01675-y
https://www.ncbi.nlm.nih.gov/pubmed/33632126
https://www.proquest.com/docview/2502790516
https://www.proquest.com/docview/2494301667
https://pubmed.ncbi.nlm.nih.gov/PMC7908643
https://doaj.org/article/1bcd5889badb4b89a3245c84715d140c
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Zj9MwELb2kBAviHsDS2UkJB4gkMOxnQeEemxVEK1WFZUqXizHTgBpaUsPif4A_jczzrFkWRAvkRKPk9gz4_kmnswQ8oyDxyWFZT4H4fAZz5mfam78SGqD6dhz4XZMxxM-mrH382R-QOpyR9UEbq517bCe1Gx98erH9_1bUPg3TuElf72BNVZgKC06xgCA_f0hOQbLxNEZG7PLXQWwhi7gHhZkH6D3vP6J5tp7tAyVy-f_56r9m9m6GlJ5ZV_VmavhbXKrwpm0WwrGHXKQL-6SG-NqJ_0e-TkoY-ygmWpjdmtt9lQ3aTrpsqDf6sq5dLXGfshC6irnUEC6FJAjxcB0JJ10hx8GFC2ipUA0nr7zzwfDIbXlQ-Aq1unONzkd6QVdNUXD7pPZ8Oxjf-RXJRl8wwOx9bNCWqaFDoO44EaGgTQpkwEzEW6oFiKWFnPA5fidMgyKMAN8kkawqBaIU4D9D8jRYrnITwi1VkRZoVMbGMG0TDQTLDNxllhY8vKs8EhYz78yVb5yLJtxoZzfIrkqeaaAZ8rxTO098qLpsyqzdfyTuodsbSgx07a7sFx_VpXiqjAzNpEyzbTNWCZTDQg0MWjTEwvOqfHIcxQKhRIKr2d09VsDDBIza6kuT2JAdWkgPHLaogQ9Nu3mWqxUrQYKAGrkUqhxjzxtmrEnxsYt8uUOaBim0A85h1s8LKWwGVIc8xjACfQWLflsjbndsvj6xWUZh8dKgKseeVlL8uVr_X1OH_33dDwmNyOnbpEfJafkaLve5U8A4G2zDjkUc9Ehx72zyfkUzvq833EfSzpOn-E47X36BTehTeo
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiDeBAkYCcQCreTi2c0Boy3a1S7urqmql3oxjJ4AE2WUfQvsD-Dv8RmbyKimit17jcRJnxvPIjL8h5KWAiEtJx5kA4WBcZJwlRlgWKmMRjj2TZcZ0MhWjU_7xLD7bIr-bszBYVtnoxFJRu5nFf-S7YKrDEkxKvJ__YNg1CrOrTQuNSiwOss1PCNmW78YD4O-rMBzun3wYsbqrALPClyuW5spxI03gR7mwKvCVTbjyuQ0xJ5jLSDmEMcvwV1vg50EKJjYJQS_kaGphBXDfa2Sb44nWHtne258eHbd5C7C3UXM0R4ndJWh_iUW-GLKDa842HfNXdgn41xb8ZQwvFmpeyNaWRnB4m9yqvVfar8TtDtnKirvk-qTOz98jvwZV5R4MU2PtemHshpoW_JPOcvq96cdL5wuch4JBy348FPxnCv4oxXJ3JJ32h4cDinbWUSCaHI_Z0WA4pK56CFzF7t_ZMqMjU9B524rsPjm9EpY8IL1iVmSPCHVOhmluEudbyY2KDZc8tVEaO1CkWZp7JGi-v7Y1Cjo24_imy2hICV3xTAPPdMkzvfHIm3bOvMIAuZR6D9naUiJ-d3lhtvisa3Wgg9S6WKkkNS7lqUoM-LWxRU8hdhDyWo-8RqHQqGXg9aypD0vAIhGvS_dFHIGvmPjSIzsdStAOtjvciJWutdNSn-8lj7xoh3EmVtwV2WwNNByB-QMh4BYPKylslxRFIgKXB2bLjnx21twdKb5-KbHL4bEKnGCPvG0k-fy1_v9NH1--iufkxuhkcqgPx9ODJ-RmWO63kIXxDumtFuvsKfiNq_RZvVkp-XTV-uEP9o16Tw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZbxMxELagSBUvFTcLBYyExAOsuofX9j6GhiiFJkKISn2zfG1Bopsox0N-AP-bGe9BtxwSr-tx9pgZz-fM-BtCXnHYcUnhWMzBOGLGPYtLzW2cSW2Rjt2LkDGdzfn0jH04L86vnOIP1e5dSrI504AsTfXmaOmqxsUlP1rDqiqweBa3wgB5491Ncoth6MN0LT_u8wgQ__LuqMwf5w3CUWDt_31tvhKcrhdOXsuehqA0uUMOWjRJR43675Ibvr5H9mdtvvw--TFuKulgmGprtyttd1T3ZJx0UdHLrj8uXa5wHiqKhv44FPAsBXxIsfwcReejyemYYtxzFIRmn0_iT-PJhLrmJnAVu3H7tadTXdNl3xrsATmbvP9yPI3bxgux5YnYxKaSjmmh0ySvuJVpIm3JZMJshmnTSuTSIdObx38j06RKDaCQMoOls0I0Akp-SPbqRe0fE-qcyEylS5dYwbQsNBPM2NwUDhY2b6qIpN33V7ZlJcfmGN9V2J1IrhqdKdCZCjpTu4i86ecsG06Of0q_Q7X2ksinHS4sVheqdU-VGusKKUujnWFGlhpwZmExchcOtqA2Iq_RKBR6PTye1e3hBXhJ5M9SI17kgN3KRETkcCAJ3mqHw51ZqXa1WCuAoVkgSuMRedkP40ysgKv9YgsyDInyU87hJx41Vti_Up7zHCAIzBYD-xy883Ck_vY1cInDbSWA0oi87Sz512P9_Zs--T_xF2QfzFGdnsw_PiW3s-B-WZwVh2Rvs9r6ZwDrNuZ58Nyfb0ZDlA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+accuracy+assessment+of+molecular+prediction+model+for+the+risk+of+NAFLD+based+on+MRI-PDFF+diagnosed+Chinese+Han+population&rft.jtitle=BMC+gastroenterology&rft.au=Zhang%2C+Qing&rft.au=Zhu%2C+Yueli&rft.au=Yu%2C+Wanjiang&rft.au=Xu%2C+Zhipeng&rft.date=2021-02-25&rft.pub=BioMed+Central+Ltd&rft.issn=1471-230X&rft.eissn=1471-230X&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1186%2Fs12876-021-01675-y&rft.externalDocID=A653663907
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-230X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-230X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-230X&client=summon